|
|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
|
Independent Review of Orathecin(TM)
Phase III Trial Supports Drug's Activity in Pancreatic Cancer
Patients who Failed Prior Treatments
SuperGen Inc. announced today that the long-term follow-up and independent review of results from the previously announced Phase III clinical program of its investigational oral anticancer compound Orathecin(TM) (rubitecan) capsules supports the drug's activity in patients with refractory pancreatic cancer who have failed prior treatments... ...full article |
||
|
||
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
||
 Home | In The News | Links | Newswire | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
||
|
|
||
|
www.pancreatica.org |
||